BGF is a prominent growth capital investor operating across the United Kingdom and Ireland, providing patient funding to small and mid-sized enterprises.
BGF backs mobile identity specialist TMT ID in its first institutional funding round to support international growth.
"We are delighted to announce BGF’s investment in TMT ID. At a time when fraud and digital threats are escalating worldwide, the ability to verify users, detect risk, and protect customers has never been more critical. TMT ID’s mobile identity and number intelligence solutions deliver real-time insights that allow enterprises to build trust, prevent fraud and optimise decision-making."
BGF and Tencent join existing shareholders to support the biotechnology company in advancing its drug development programmes.
"We are delighted to have significantly added to our Series A financing, which we see as a strong validation of both our technology and our progress to date. I would like to thank Tencent and BGF for their belief in our potential, as well as all our existing investors for their continued support."
The financing round was backed by BGF, Parkwalk, and Meltwind to drive therapeutics discovery in autoimmune and other common diseases.
"Our founders have led the field by developing technology to map 3D interactions on a whole-genome scale, and integrating these data with comprehensive multi-omics datasets. We now have the technological capabilities to decipher the causal biology that drives complex and common genetic diseases, with the potential to develop truly effective new blockbuster therapies."
The financing round was led by EQT Life Sciences alongside co-leads Advent Life Sciences and British Business Bank.
"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
BGF provides funding in its first deployment under a £300m pledge for female-led businesses.
"This investment from BGF comes at an exciting time for CWC Group and will enable us to take the next steps towards developing our care services and our footprint in Northern Ireland. We have a solid pipeline of new specialist care homes that will help us further support NI Trusts with high-quality, dedicated care for adults with specialist needs."
